SlideShare a Scribd company logo
APPROACH TO
PAEDIATRIC CATARACT
PREVALENCE
◦ 1.5 million children blind worldwide.
◦ Paediatric cataract accounts for 7.4%-15.3% of paediatric
blindness.
◦ The prevalence of childhood cataract is about 1.03/10,000
children.
◦ Approx. 40,000 children with cataract in india
ETIOLOGY AND ASSOCIATIONS OF
PAEDIATRIC CATARACT
◦ Congenital cataract is associated with
- ocular abnormalities in 27% of cases
- systemic abnormalities in 22% of cases
◦ Most unilateral and a significant number of bilateral
cataracts are idiopathic in nature.
◦ Crystallin and connexin gene mutations are the most
commonly described non-syndromic inherited cataracts.
ETIOLOGY OF PAEDIATRIC CATARACT
◦ Idiopathic –M/C
◦ Genetic-congenital cataract is hereditary in 8.3-25% of cases,with 75% being AD in inheritance.
◦ Intra-uterine infections-10-15%(rubella,varicella,toxoplasmosis,herpes simplex).
◦ Metabolic-8-10%(galactosemia,hypocalcemia,hypoglycemia,dehydration)
◦ Trauma-20-30%
◦ Prematurity
◦ Syndromic
A-zonular cataract with riders ,B-cataract pulverulenta,C-Anterior polar cataract(plaque type),
D-anterior polar cataract(pyramidal type),E-Posterior lenticonus(oildroplet sign),F-posterior polar cataract,G-
sutural cataract,H-morgagnian cataract
WORK-UP
History
Ocular examination
Laboratory studies
Paediatric evaluation
HISTORY
Parents of child come with following complaints-
1.Failure of response to visual targets
2.White pupillary reflex
3.Lack of fixation
4.Deviated eye
5.Nystagmus
HISTORY
Age of onset, duration of symptoms
Maternal history (infection,rash,drug use)
Developmental history, milestones
History of LBW and pre-term delivery
Any history suggestive of any associated systemic
abnormality
Trauma, Previous treatment, or surgery
Family history of congenital cataract and consanguinity
VISUAL ASSESSMENT
• PREVERBAL CHILDREN
#Fixation Behavior-fix and follow light,
CSM method
#Preferential looking test
-Teller acuity cards
-Visual evoked potential (VEP)
#Optokinetic nystagmus drum
VISUAL ASSESSMENT
VERBAL CHILDREN
Landolt c
Allen picture cards
Snellen’s chart
Tumbling E
LEA symbols
Log MAR
Anterior segment
examination
Slit-lamp Exam / Torch light
Morphology-size,density,location and its laterality
Associated anomalies of cornea,iris and anterior
chamber,pupil
Intraocular pressure/squint/nystagmus
Examination of
The Red Reflex
◦ k/c/o Bruckner test
◦ For detection of visual axis
opacities,strabismus,refractive errors and
retinal abnormalities.
◦ Done by DDO
◦ To assess density and morphology of
cataract.
Posterior segment
examination
Dilated fundus examination-to look for any post
segment anomaly
R/O vitreous haemorrhage,RD,persistent foetal
vasculature or any intraocular mass in the post
segment
Ultrasound B-scan-if fundus is not visible by IO
Visually significant cataract
◦ Centrally or posteriorly located
◦ Size >3mm
◦ Visual acuity < 20/60
◦ Decrease in contrast sensitivity
◦ Increased glare
◦ Loss of stereo acuity
◦ Not able to observe the disc and macula with direct ophthalmoscope,especially on dilated pupil
◦ Congenital sensory nystagmus,strabismus
Laboratory Investigations
Complete hemogram
Blood sugar
Urine routine microscopy
Serum calcium and phosphate levels for hyper or hypoparathyroidism.
VDRL for syphilis
Antibody titer for TORCH.
Red cell galactokinase or uridyl transferase for galactosemia
Urine protein for Alport syndrome
Urine amino acid for Lowe syndrome
Urine sodium nitroprusside/ plasma homocysteine for homocystinuria
Urine/serum copper for Wilson disease
Karyotyping for a genetic defect
GA work up
MANAGEMENT
Surgical or conservative mx ?
If surgery,then what?
Primary IOL implantation ?
If not,how to manage aphakia?
NON-SURGICAL
Cataracts not in visual axis
In visual axis but <3mm diameter
Rx-Mydriatrics with part time occlusion of the better eye
But prolonged cycloplegia causes amblyopia-early sx reqd
SURGICAL-INDICATIONS
Visually significant cataract-U/L or B/L
U/L dense cataracts
Central and >3mm
Cataract with Strabismus
Cataract with nystagmus or unsteady fixation
One eye operated in a binocular cataract
Poor retinoscopic reflex
Small eyes/low scleral
rigidity
Positive pressure/elastic
AC/difficult rhexis
Biometry IOL power
calculation
Increased inflammatory
response/constant
change in refractive error
Glaucoma/amblyopia/gla
sses
Post-op mx of
aphakia/amblyopia
CHALLENGES
TIMING OF
SURGERY
Dense visually significant B/L cataract-
6-8 weeks of age (Each eye one week
apart- to prevent amblyopia)
U/L visually significant cataract -4-6
weeks
B/L cataract detected later-surgery as
soon as possible.First on the worse
eye.
Techniques of biometry
◦ Hand-held keratometer- lack of fixation and centration
◦ Inaccurate keratometric values-error of 0.8-1.3 D in children
◦ Obtaining multiple readings of the same and recording the
average K reading
◦ K readings without speculum are preferred (causes globe
deformation and gives unreliable readings)
Techniques of biometry
◦ Inaccurate AL in paediatric eyes - 4-14 D of error for each
mm difference
◦ For contact A-Scan,the value with maximum AC depth
chosen to offset the inadvertent indentation of the cornea.
◦ Immersion A-Scan is considered gold standard
IOL formulae
AL <20mm- SRK/T and the
Holladay 2 formulae
OLDER CHILDREN(>2yrs)
AL<22 MM –Hoffer Q formula
AL>22 MM- Barrett and SRK/T
formulas are better
IOL POWER CALCULATION
Aim for moderately hypermetropic postoperative refractive
outcome to compensate for myopic shift which is expected
in children due to axial elongation of the globe.
IOL can be implanted in eyes with an AL >17mm and
corneal diameter >10mm
IOL POWER CALCULATION
◦ Dahan’s criteria:
◦ <2 yrs-undercorrect by 20%
◦ 2-8 yrs-undercorrect by 10%
◦ DAHAN’S GUIDELINES
◦ Hiles and Atkinson criteria:
◦ <2 yrs-20-50% undercorrect
◦ >2 yrs-emmetropic
AXIAL LENGTH (MM) IOL POWER(D)
17 28
18 27
19 26
20 24
21 22
IOL SIZE
In children <2 yrs,smaller size (10-10.5mm)IOL
must be used
Adult size IOL (12-13.5mm) well tolerated in
children >2 yrs d/t elastic nature of the capsule
Optic size-5.5-6.5mm ensures adequate
pupillary coverage in case of decentration
IOL MATERIAL
Acrylic Hydrophobic foldable IOL’s – Increased uveal
biocompatibility,reduced post-op inflammation and
PCO rates
Single piece PMMA,preferably heparin coated-
reduce deposits on IOL surface
Children with juvenile rheumatoid
arthritis,microcornea,microphthalmos,severe
persistent foetal vasculature are left aphakic.
IOL implantation ??
• IOL IMPLANTATION BEFORE 1 YR OF AGE CONTROVERSIAL
• Difference in size of globe compared to adult eye & rapid growth(AL,corneal curvature,lens
diameter&sulcus size). Unpredictable refractive status
• Technical difficulty of implanting IOL in very small eyes
• Greater inflammatory response
• Secondary glaucoma
• VAO
• Most surgeons prefer implant after 18-24 months of age
• Most of the growth of eye has occurred by this time
• IOL power calculation is more predictable
SURGICAL PRINCIPLES
General Anaesthesia and EUA
Lid speculum applied
Superior rectus suture
Wound construction
Anterior capsulorrhexis
Irrigation and aspiration
Primary posterior capsulorrhexis
Anterior vitrectomy
IOL implantation
Closure of wound with a suture
General Anaesthesia and
EUA
Systemic co-morbidities
Seizure disorders/developmental
disorders
Corneal diameter/biometry/IOP/IOL
power cal/gonioscopy/pachymetry
R/o NLD obstruction
WOUND CONSTRUCTION
◦ LENSECTOMY
◦ -Limbal route/pars plana route
◦ -limbal:preservation of bag/360 capsular
rim for secondary IOL
◦ -pars plana-2 side ports with MVR blade
◦ LENS ASPIRATION WITH PRIMARY IOL
◦ -clear corneal/scleral tunnel
◦ -2.8mm clear corneal main incision-
preferred-foldable IOLs
◦ -5.5mm scleral tunnel-rigid PMMA IOLs
Pre-
requisites for
ACC
Adequate pupillary dilatation
Improve visualization-use high
magnification and dim OT lights
Avoid positive vitreous pressure-
pre-op iv mannitol may be reqd
Viscolelastic-highly cohesive,use
liberally
Challenges –ACC
◦ A.)VERY ELASTIC CAPSULE-
◦ Deforms without tearing
◦ When it finally tears,the force of the rebound propagates the
tear rapidly and uncontrollably to the periphery
◦ B.)LOW SCLERAL RIGIDITY
◦ Positive vitreous pressure shallowing of ac anterior surface
of the lens becomes convex rhexis runs to periphery
C.)DIFFICULT TO USE CYSTITOME
Difficult to advance the everted capsular flap over soft cortex
Less control over rhexis tends to extend
D.)RHEXIS FORCEPS
Better control over rhexis
Utrata chances of AC shallowing as it is passed through main incision
Special end-gripping type of rhexis forceps
Introduced through side-port AC well-maintained
Technique-ACC
◦ INITIAL CENTRAL PERFORATION-forceps -bent 26 G needle
◦ REST OF RHEXIS
◦ Forceps only
◦ Centripetal force instead of usual tangential (ripping technique)
◦ Peformed slowly with repeated re-grasping of flap just adjacent to edge of tear to prevent
peripheral extension
◦ Always keep AC well-formed with visco-elastic
◦ Aim for small rhexis size as it enlarges due to elasticity
◦ Ideal size-5-5.5 mm
◦ ACC-smaller than the IOL optic diameter(6mm)
◦ RHEXIS BY RIPPING
◦ Flap pulled perpendicular to rhexis edge(i.e.towards
centre)
◦ Only this method can tear the elastic capsule of children
Other options
◦ VITRECTORRHEXIS
◦ Cutting rate 150-300
◦ Aspiration rate 150-200cc/min
◦ 2 incision push-pull technique
◦ -2 small incisions superior & inferior
◦ -grasp the centre of flap of superior
incision & push towards centre-
semicircular tear
◦ -grasp the centre of flap of inferior incision
& pull towards centre-semicircular tear
RADIOFREQUENCY DIATHERMY
CAPSULOTOMY
High frequency current of 500khz
Platinum alloy tip probe heated to 160
F
Anterior capsulorrhexis
Poor visibility/total
cataracts
Shallow AC
Tendency to run off
High PP from
vitreous
Elastic anterior
capsule
Run-off
Irrigation and
Aspiration
Nucleus is very soft - Hence NO PHACO ENERGY needed
Bimanual/co-axial probe-faster,maintains AC and prevents hypotony,hence
pupillary miosis.
Remove entire lens matter/cortex
Polish the posterior capsule before PPC.
Membranous /calcified cataracts may require phacoemulsification
Primary
posterior
capsulorhexis
Indicated in children <6years
Planned posterior capsulotomy performed
-to prevent inevitable PCO formation
-to remove PC plaque
-to allow posterior capture of IOL optic
-to prevent radial extension when small PC rupture
occurs inadvertently
-to provide more tear resistant edge for anterior
vitrectomy and IOL implantation
Pre-
requisites for
PPC
Excellent visibility – good
microscope,clear
cornea,sufficient mydriasis
No positive pressure
Technique-PPC
◦ Viscoelastic injected in capsular bag
after cortical clean up-flattens PC by
countering vitreous pressure
◦ Central perforation with cystitome in
front of retrolental space of berger
◦ Central perforation
◦ -26G cystitome descends at a slant
◦ -PC engaged and punctured
◦ -small flap created by pushing margin inferiorly
◦ Small amount of viscoelastic injected into capsular hole
◦ -separates PC from vitreous
◦ -should be done slowly to avoid extension of tear to
periphery
◦ Rhexis commenced with either utrata or end-
gripping forceps
◦ -proceed slowly with repeated re-grasping of the
leading edge in manner similar to anterior rhexis
◦ Rhexis size-
◦ -1.5-2mm smaller than IOL optic to reconstitute
barrier between vitreous and anterior chamber
◦ -too small or too big will prevent IOL optic capture
Anterior vitrectomy
Intact anterior vitreous face(AVF) acts as scaffold for lens epithelial cells
to grow-chances of VAO higher
Mandatory in infants and younger children
Maybe deferred in children >7years
Limbal/transconjuctival pars plana approach
Rates of PCO decreases only after AV not PCCC alone in children<6 years
CURRENT RECOMMENDATION—
Primary PCCC with AV for children <6-7 yrs of age
Primary PCCC without AV for >7 yrs of age
PC left intact in children >9-10 yrs of age
IOL Implantation
o Standard care-over 1 yr of age;infants-controversial?
o Single piece hydrophobic acrylic IOL in the bag;inflate
bag well with healon GV
◦ 3 piece IOL in sulcus
◦ Optic capture
◦ Bag in the lens technique
IOL FIXATION SITES
◦ Haptics in bag & optic capture by PCCC
◦ Haptics & optic in bag (if PCCC too large or small for IOL
capture)
◦ Haptics in sulcus & optic capture by PCCC(if incomplete
anterior rhexis but complete PCCC)
◦ Haptics in sulcus & optic capture by anterior rhexis(if
completenanterior rhexis but incomplete PCCC)
◦ Haptic in sulcus & optic in front of anterior capsule (if
incomplete anterior rhexis & PCCC)
Wound closure
◦ Wash all viscoelastic!
◦ Look for any peeking of rhexis/pupil-cut vitreous before wound closure
◦ LMW heparin solution(5IU in 500ml) may be used for irrigation to reduce chances of
inflammation
◦ ALWAYS suture all the wounds (low scleral rigidity-not self-sealing wound)
◦ 10-0 vicryl/10-0 monofilament nylon suture
◦ Side ports may be left unsutured in older children if well constructed and no leak at the end of
the procedure
Post-op management
◦ Surgery is only the first and the easiest step!
◦ Topical steroids hourly doses tapered gradually
◦ Topical antibiotics broad spectrum
◦ Topical cycloplegics
◦ Oral steroids in special cases
Management of aphakia
◦ SPECTACLES
◦ -B/L aphakia
◦ -most children adapt well and develop
good visual responses
◦ -poor quality of vision;increased incidence
of strabismus
◦ Poor cosmesis
◦ CONTACT LENSES
◦ -U/L and B/L aphakia
◦ -RGP/Silicone/hydrogel
◦ -better optical correction;comparable
results to primary IOL implantation
◦ -difficult to insert/costly
◦ -risk of infection/intolerence
Management of pseudophakia
◦ Undercorrection-less chances for higher myopic shift
and IOL exchange at later date
◦ Spectacles-given as soon as surgery is done!
◦ Single vision correction for young infants;bifocals for
toddlers;progressive glasses may be considered for
older children
◦ Secondary IOL implantation in the sulcus-for
aphakic cases @ 4-5 yrs of age
COMPLICATIONS
◦ Post-op inflammation(fibrin/exudates)-start oral steriods
◦ Glaucoma
◦ Posterior capsular opacification
◦ Secondary membranes
◦ Pupillary capture of IOL/IOL decentration
Amblyopia
◦ U/L cases most difficult to manage
◦ Starts right after surgery-aggressive part time occlusion
◦ B/L cases-check for fixation preference/BCVA at follow up visit and decide for PTO
THANK YOU!

More Related Content

Similar to approach to padiatric cataract 2.pptx

Complex cases in Cataract surgery and its management.pptx
 Complex cases in Cataract surgery and its management.pptx Complex cases in Cataract surgery and its management.pptx
Complex cases in Cataract surgery and its management.pptx
MadhumitaBooks
 
Pre and post operative management of cataract
Pre and post operative management of cataractPre and post operative management of cataract
Pre and post operative management of cataract
kalpanabhandari19
 
Penetrating Keratoplasty
Penetrating Keratoplasty Penetrating Keratoplasty
Penetrating Keratoplasty
Jigyasa Sahu
 
Management of congenital cataract
Management of congenital cataractManagement of congenital cataract
Management of congenital cataract
Sai Sandeep
 
Complex cases in Cataract surgery and its management.pptx
Complex cases in Cataract surgery and its management.pptxComplex cases in Cataract surgery and its management.pptx
Complex cases in Cataract surgery and its management.pptx
DrMadhumita Prasad
 
Preoperative evaluation for LASIK & PRK
Preoperative evaluation for LASIK & PRKPreoperative evaluation for LASIK & PRK
Preoperative evaluation for LASIK & PRK
Basrah Teaching Hspital
 
myopia-141210010058-conversion-gate01.pdf
myopia-141210010058-conversion-gate01.pdfmyopia-141210010058-conversion-gate01.pdf
myopia-141210010058-conversion-gate01.pdf
Divya720549
 
Basal cell carcinoma A case report.pptx
Basal cell carcinoma A case report.pptxBasal cell carcinoma A case report.pptx
Basal cell carcinoma A case report.pptx
DrkainatSaleem
 
Corneal Ectasias
Corneal Ectasias Corneal Ectasias
Corneal Ectasias
Vineela Cherukuri
 
REFRACTIVE LENS EXCHANGE(CLEAR LENS EXTRACTION).pptx by sudhakar.pptx
REFRACTIVE  LENS EXCHANGE(CLEAR LENS EXTRACTION).pptx by sudhakar.pptxREFRACTIVE  LENS EXCHANGE(CLEAR LENS EXTRACTION).pptx by sudhakar.pptx
REFRACTIVE LENS EXCHANGE(CLEAR LENS EXTRACTION).pptx by sudhakar.pptx
sudhakarnaidulaveti
 
Keratoconus - Dr Shylesh B Dabke
Keratoconus - Dr Shylesh B DabkeKeratoconus - Dr Shylesh B Dabke
Keratoconus - Dr Shylesh B Dabke
Shylesh Dabke
 
Retinal complications of LASIK- DR AJAY DUDANI
Retinal complications of LASIK- DR AJAY DUDANIRetinal complications of LASIK- DR AJAY DUDANI
Retinal complications of LASIK- DR AJAY DUDANI
AjayDudani1
 
Childhood cataracts
Childhood cataractsChildhood cataracts
Childhood cataracts
Panit Cherdchu
 
A-scan in special cases
A-scan in special cases  A-scan in special cases
A-scan in special cases
bharti vidhyapeeth university,Pune
 
BIOMETERY
BIOMETERYBIOMETERY
Retinal detachment
Retinal detachmentRetinal detachment
Retinal detachment
MEDICS india
 
Contact Lens Options In Keratoconus Patients
Contact Lens Options In Keratoconus Patients Contact Lens Options In Keratoconus Patients
Contact Lens Options In Keratoconus Patients
Simran Pahuja
 
Case report on keratoconus management
Case report on keratoconus managementCase report on keratoconus management
Case report on keratoconus management
Meenakshi Jha
 
Cataract surgery
Cataract surgeryCataract surgery
Cataract surgery
Irawati Sarode
 
KERATOCONUS
KERATOCONUSKERATOCONUS
KERATOCONUS
MadhumitaBooks
 

Similar to approach to padiatric cataract 2.pptx (20)

Complex cases in Cataract surgery and its management.pptx
 Complex cases in Cataract surgery and its management.pptx Complex cases in Cataract surgery and its management.pptx
Complex cases in Cataract surgery and its management.pptx
 
Pre and post operative management of cataract
Pre and post operative management of cataractPre and post operative management of cataract
Pre and post operative management of cataract
 
Penetrating Keratoplasty
Penetrating Keratoplasty Penetrating Keratoplasty
Penetrating Keratoplasty
 
Management of congenital cataract
Management of congenital cataractManagement of congenital cataract
Management of congenital cataract
 
Complex cases in Cataract surgery and its management.pptx
Complex cases in Cataract surgery and its management.pptxComplex cases in Cataract surgery and its management.pptx
Complex cases in Cataract surgery and its management.pptx
 
Preoperative evaluation for LASIK & PRK
Preoperative evaluation for LASIK & PRKPreoperative evaluation for LASIK & PRK
Preoperative evaluation for LASIK & PRK
 
myopia-141210010058-conversion-gate01.pdf
myopia-141210010058-conversion-gate01.pdfmyopia-141210010058-conversion-gate01.pdf
myopia-141210010058-conversion-gate01.pdf
 
Basal cell carcinoma A case report.pptx
Basal cell carcinoma A case report.pptxBasal cell carcinoma A case report.pptx
Basal cell carcinoma A case report.pptx
 
Corneal Ectasias
Corneal Ectasias Corneal Ectasias
Corneal Ectasias
 
REFRACTIVE LENS EXCHANGE(CLEAR LENS EXTRACTION).pptx by sudhakar.pptx
REFRACTIVE  LENS EXCHANGE(CLEAR LENS EXTRACTION).pptx by sudhakar.pptxREFRACTIVE  LENS EXCHANGE(CLEAR LENS EXTRACTION).pptx by sudhakar.pptx
REFRACTIVE LENS EXCHANGE(CLEAR LENS EXTRACTION).pptx by sudhakar.pptx
 
Keratoconus - Dr Shylesh B Dabke
Keratoconus - Dr Shylesh B DabkeKeratoconus - Dr Shylesh B Dabke
Keratoconus - Dr Shylesh B Dabke
 
Retinal complications of LASIK- DR AJAY DUDANI
Retinal complications of LASIK- DR AJAY DUDANIRetinal complications of LASIK- DR AJAY DUDANI
Retinal complications of LASIK- DR AJAY DUDANI
 
Childhood cataracts
Childhood cataractsChildhood cataracts
Childhood cataracts
 
A-scan in special cases
A-scan in special cases  A-scan in special cases
A-scan in special cases
 
BIOMETERY
BIOMETERYBIOMETERY
BIOMETERY
 
Retinal detachment
Retinal detachmentRetinal detachment
Retinal detachment
 
Contact Lens Options In Keratoconus Patients
Contact Lens Options In Keratoconus Patients Contact Lens Options In Keratoconus Patients
Contact Lens Options In Keratoconus Patients
 
Case report on keratoconus management
Case report on keratoconus managementCase report on keratoconus management
Case report on keratoconus management
 
Cataract surgery
Cataract surgeryCataract surgery
Cataract surgery
 
KERATOCONUS
KERATOCONUSKERATOCONUS
KERATOCONUS
 

More from Harshika Malik

artifical intelligence in ophthalmology.pptx
artifical intelligence in ophthalmology.pptxartifical intelligence in ophthalmology.pptx
artifical intelligence in ophthalmology.pptx
Harshika Malik
 
Retinal Dystrophy.pptx vvvvvvvvvvvvvvvvv
Retinal Dystrophy.pptx vvvvvvvvvvvvvvvvvRetinal Dystrophy.pptx vvvvvvvvvvvvvvvvv
Retinal Dystrophy.pptx vvvvvvvvvvvvvvvvv
Harshika Malik
 
ECTROPION^JENTROPION AND THEIR MANAGEMENT 2.pptx
ECTROPION^JENTROPION AND THEIR MANAGEMENT 2.pptxECTROPION^JENTROPION AND THEIR MANAGEMENT 2.pptx
ECTROPION^JENTROPION AND THEIR MANAGEMENT 2.pptx
Harshika Malik
 
EPISCLERITIS AND SCLERITIS.pptx bbbbbbbb
EPISCLERITIS AND SCLERITIS.pptx bbbbbbbbEPISCLERITIS AND SCLERITIS.pptx bbbbbbbb
EPISCLERITIS AND SCLERITIS.pptx bbbbbbbb
Harshika Malik
 
PENETRATING KERATOPLASTY - Cmmmmopy.pptx
PENETRATING KERATOPLASTY - Cmmmmopy.pptxPENETRATING KERATOPLASTY - Cmmmmopy.pptx
PENETRATING KERATOPLASTY - Cmmmmopy.pptx
Harshika Malik
 
LAMELLAR KERATOPLASTY.pptx vvvvvvvvvvvvvv
LAMELLAR KERATOPLASTY.pptx vvvvvvvvvvvvvvLAMELLAR KERATOPLASTY.pptx vvvvvvvvvvvvvv
LAMELLAR KERATOPLASTY.pptx vvvvvvvvvvvvvv
Harshika Malik
 
rop.pptx
rop.pptxrop.pptx
rop.pptx
Harshika Malik
 
TED.pptx
TED.pptxTED.pptx
TED.pptx
Harshika Malik
 
proptosis.pptx
proptosis.pptxproptosis.pptx
proptosis.pptx
Harshika Malik
 
Mechanical_ocular_trauma.pptx
Mechanical_ocular_trauma.pptxMechanical_ocular_trauma.pptx
Mechanical_ocular_trauma.pptx
Harshika Malik
 
retinal_detachment 4.pptx
retinal_detachment 4.pptxretinal_detachment 4.pptx
retinal_detachment 4.pptx
Harshika Malik
 
squint copy.pptx
squint copy.pptxsquint copy.pptx
squint copy.pptx
Harshika Malik
 
diabetic_retinopathy copy.pptx
diabetic_retinopathy copy.pptxdiabetic_retinopathy copy.pptx
diabetic_retinopathy copy.pptx
Harshika Malik
 
830_Optic_nerve_final copy 2.pptx
830_Optic_nerve_final copy 2.pptx830_Optic_nerve_final copy 2.pptx
830_Optic_nerve_final copy 2.pptx
Harshika Malik
 
retinoblastoma 2.pptx
retinoblastoma 2.pptxretinoblastoma 2.pptx
retinoblastoma 2.pptx
Harshika Malik
 
Secondary-glaucoma-Final.pptx
Secondary-glaucoma-Final.pptxSecondary-glaucoma-Final.pptx
Secondary-glaucoma-Final.pptx
Harshika Malik
 
aion.pptx
aion.pptxaion.pptx
aion.pptx
Harshika Malik
 
lacrimal apparatus.pptx
lacrimal apparatus.pptxlacrimal apparatus.pptx
lacrimal apparatus.pptx
Harshika Malik
 
catarcact-ug1 2.pptx
catarcact-ug1 2.pptxcatarcact-ug1 2.pptx
catarcact-ug1 2.pptx
Harshika Malik
 
1167_Anterior-Uveitis 2.pptx
1167_Anterior-Uveitis 2.pptx1167_Anterior-Uveitis 2.pptx
1167_Anterior-Uveitis 2.pptx
Harshika Malik
 

More from Harshika Malik (20)

artifical intelligence in ophthalmology.pptx
artifical intelligence in ophthalmology.pptxartifical intelligence in ophthalmology.pptx
artifical intelligence in ophthalmology.pptx
 
Retinal Dystrophy.pptx vvvvvvvvvvvvvvvvv
Retinal Dystrophy.pptx vvvvvvvvvvvvvvvvvRetinal Dystrophy.pptx vvvvvvvvvvvvvvvvv
Retinal Dystrophy.pptx vvvvvvvvvvvvvvvvv
 
ECTROPION^JENTROPION AND THEIR MANAGEMENT 2.pptx
ECTROPION^JENTROPION AND THEIR MANAGEMENT 2.pptxECTROPION^JENTROPION AND THEIR MANAGEMENT 2.pptx
ECTROPION^JENTROPION AND THEIR MANAGEMENT 2.pptx
 
EPISCLERITIS AND SCLERITIS.pptx bbbbbbbb
EPISCLERITIS AND SCLERITIS.pptx bbbbbbbbEPISCLERITIS AND SCLERITIS.pptx bbbbbbbb
EPISCLERITIS AND SCLERITIS.pptx bbbbbbbb
 
PENETRATING KERATOPLASTY - Cmmmmopy.pptx
PENETRATING KERATOPLASTY - Cmmmmopy.pptxPENETRATING KERATOPLASTY - Cmmmmopy.pptx
PENETRATING KERATOPLASTY - Cmmmmopy.pptx
 
LAMELLAR KERATOPLASTY.pptx vvvvvvvvvvvvvv
LAMELLAR KERATOPLASTY.pptx vvvvvvvvvvvvvvLAMELLAR KERATOPLASTY.pptx vvvvvvvvvvvvvv
LAMELLAR KERATOPLASTY.pptx vvvvvvvvvvvvvv
 
rop.pptx
rop.pptxrop.pptx
rop.pptx
 
TED.pptx
TED.pptxTED.pptx
TED.pptx
 
proptosis.pptx
proptosis.pptxproptosis.pptx
proptosis.pptx
 
Mechanical_ocular_trauma.pptx
Mechanical_ocular_trauma.pptxMechanical_ocular_trauma.pptx
Mechanical_ocular_trauma.pptx
 
retinal_detachment 4.pptx
retinal_detachment 4.pptxretinal_detachment 4.pptx
retinal_detachment 4.pptx
 
squint copy.pptx
squint copy.pptxsquint copy.pptx
squint copy.pptx
 
diabetic_retinopathy copy.pptx
diabetic_retinopathy copy.pptxdiabetic_retinopathy copy.pptx
diabetic_retinopathy copy.pptx
 
830_Optic_nerve_final copy 2.pptx
830_Optic_nerve_final copy 2.pptx830_Optic_nerve_final copy 2.pptx
830_Optic_nerve_final copy 2.pptx
 
retinoblastoma 2.pptx
retinoblastoma 2.pptxretinoblastoma 2.pptx
retinoblastoma 2.pptx
 
Secondary-glaucoma-Final.pptx
Secondary-glaucoma-Final.pptxSecondary-glaucoma-Final.pptx
Secondary-glaucoma-Final.pptx
 
aion.pptx
aion.pptxaion.pptx
aion.pptx
 
lacrimal apparatus.pptx
lacrimal apparatus.pptxlacrimal apparatus.pptx
lacrimal apparatus.pptx
 
catarcact-ug1 2.pptx
catarcact-ug1 2.pptxcatarcact-ug1 2.pptx
catarcact-ug1 2.pptx
 
1167_Anterior-Uveitis 2.pptx
1167_Anterior-Uveitis 2.pptx1167_Anterior-Uveitis 2.pptx
1167_Anterior-Uveitis 2.pptx
 

Recently uploaded

Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
Medical Quiz ( Online Quiz for API Meet 2024 ).pdfMedical Quiz ( Online Quiz for API Meet 2024 ).pdf
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
Jim Jacob Roy
 
Osteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdfOsteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdf
Jim Jacob Roy
 
Outbreak management including quarantine, isolation, contact.pptx
Outbreak management including quarantine, isolation, contact.pptxOutbreak management including quarantine, isolation, contact.pptx
Outbreak management including quarantine, isolation, contact.pptx
Pratik328635
 
Tests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptxTests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptx
taiba qazi
 
Ketone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistryKetone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistry
Dhayanithi C
 
Travel Clinic Cardiff: Health Advice for International Travelers
Travel Clinic Cardiff: Health Advice for International TravelersTravel Clinic Cardiff: Health Advice for International Travelers
Travel Clinic Cardiff: Health Advice for International Travelers
NX Healthcare
 
Chapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptxChapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptx
Earlene McNair
 
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptxMuscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
rishi2789
 
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
rishi2789
 
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.GawadHemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
NephroTube - Dr.Gawad
 
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
rishi2789
 
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
FFragrant
 
share - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptxshare - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptx
Tina Purnat
 
vonoprazan A novel drug for GERD presentation
vonoprazan A novel drug for GERD presentationvonoprazan A novel drug for GERD presentation
vonoprazan A novel drug for GERD presentation
Dr.pavithra Anandan
 
Efficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in AyurvedaEfficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in Ayurveda
Dr. Jyothirmai Paindla
 
Cervical Disc Arthroplasty ORSI 2024.pptx
Cervical Disc Arthroplasty ORSI 2024.pptxCervical Disc Arthroplasty ORSI 2024.pptx
Cervical Disc Arthroplasty ORSI 2024.pptx
LEFLOT Jean-Louis
 
Complementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLSComplementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLS
chiranthgowda16
 
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấuK CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
HongBiThi1
 
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
19various
 

Recently uploaded (20)

Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
Medical Quiz ( Online Quiz for API Meet 2024 ).pdfMedical Quiz ( Online Quiz for API Meet 2024 ).pdf
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
 
Osteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdfOsteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdf
 
Outbreak management including quarantine, isolation, contact.pptx
Outbreak management including quarantine, isolation, contact.pptxOutbreak management including quarantine, isolation, contact.pptx
Outbreak management including quarantine, isolation, contact.pptx
 
Tests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptxTests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptx
 
Ketone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistryKetone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistry
 
Travel Clinic Cardiff: Health Advice for International Travelers
Travel Clinic Cardiff: Health Advice for International TravelersTravel Clinic Cardiff: Health Advice for International Travelers
Travel Clinic Cardiff: Health Advice for International Travelers
 
Chapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptxChapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptx
 
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptxMuscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
 
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
 
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
 
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.GawadHemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
 
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
 
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
 
share - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptxshare - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptx
 
vonoprazan A novel drug for GERD presentation
vonoprazan A novel drug for GERD presentationvonoprazan A novel drug for GERD presentation
vonoprazan A novel drug for GERD presentation
 
Efficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in AyurvedaEfficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in Ayurveda
 
Cervical Disc Arthroplasty ORSI 2024.pptx
Cervical Disc Arthroplasty ORSI 2024.pptxCervical Disc Arthroplasty ORSI 2024.pptx
Cervical Disc Arthroplasty ORSI 2024.pptx
 
Complementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLSComplementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLS
 
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấuK CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
 
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
 

approach to padiatric cataract 2.pptx

  • 2. PREVALENCE ◦ 1.5 million children blind worldwide. ◦ Paediatric cataract accounts for 7.4%-15.3% of paediatric blindness. ◦ The prevalence of childhood cataract is about 1.03/10,000 children. ◦ Approx. 40,000 children with cataract in india
  • 3. ETIOLOGY AND ASSOCIATIONS OF PAEDIATRIC CATARACT ◦ Congenital cataract is associated with - ocular abnormalities in 27% of cases - systemic abnormalities in 22% of cases ◦ Most unilateral and a significant number of bilateral cataracts are idiopathic in nature. ◦ Crystallin and connexin gene mutations are the most commonly described non-syndromic inherited cataracts.
  • 4. ETIOLOGY OF PAEDIATRIC CATARACT ◦ Idiopathic –M/C ◦ Genetic-congenital cataract is hereditary in 8.3-25% of cases,with 75% being AD in inheritance. ◦ Intra-uterine infections-10-15%(rubella,varicella,toxoplasmosis,herpes simplex). ◦ Metabolic-8-10%(galactosemia,hypocalcemia,hypoglycemia,dehydration) ◦ Trauma-20-30% ◦ Prematurity ◦ Syndromic
  • 5. A-zonular cataract with riders ,B-cataract pulverulenta,C-Anterior polar cataract(plaque type), D-anterior polar cataract(pyramidal type),E-Posterior lenticonus(oildroplet sign),F-posterior polar cataract,G- sutural cataract,H-morgagnian cataract
  • 7. HISTORY Parents of child come with following complaints- 1.Failure of response to visual targets 2.White pupillary reflex 3.Lack of fixation 4.Deviated eye 5.Nystagmus
  • 8. HISTORY Age of onset, duration of symptoms Maternal history (infection,rash,drug use) Developmental history, milestones History of LBW and pre-term delivery Any history suggestive of any associated systemic abnormality Trauma, Previous treatment, or surgery Family history of congenital cataract and consanguinity
  • 9. VISUAL ASSESSMENT • PREVERBAL CHILDREN #Fixation Behavior-fix and follow light, CSM method #Preferential looking test -Teller acuity cards -Visual evoked potential (VEP) #Optokinetic nystagmus drum
  • 10. VISUAL ASSESSMENT VERBAL CHILDREN Landolt c Allen picture cards Snellen’s chart Tumbling E LEA symbols Log MAR
  • 11. Anterior segment examination Slit-lamp Exam / Torch light Morphology-size,density,location and its laterality Associated anomalies of cornea,iris and anterior chamber,pupil Intraocular pressure/squint/nystagmus
  • 12. Examination of The Red Reflex ◦ k/c/o Bruckner test ◦ For detection of visual axis opacities,strabismus,refractive errors and retinal abnormalities. ◦ Done by DDO ◦ To assess density and morphology of cataract.
  • 13. Posterior segment examination Dilated fundus examination-to look for any post segment anomaly R/O vitreous haemorrhage,RD,persistent foetal vasculature or any intraocular mass in the post segment Ultrasound B-scan-if fundus is not visible by IO
  • 14. Visually significant cataract ◦ Centrally or posteriorly located ◦ Size >3mm ◦ Visual acuity < 20/60 ◦ Decrease in contrast sensitivity ◦ Increased glare ◦ Loss of stereo acuity ◦ Not able to observe the disc and macula with direct ophthalmoscope,especially on dilated pupil ◦ Congenital sensory nystagmus,strabismus
  • 15.
  • 16. Laboratory Investigations Complete hemogram Blood sugar Urine routine microscopy Serum calcium and phosphate levels for hyper or hypoparathyroidism. VDRL for syphilis Antibody titer for TORCH. Red cell galactokinase or uridyl transferase for galactosemia Urine protein for Alport syndrome Urine amino acid for Lowe syndrome Urine sodium nitroprusside/ plasma homocysteine for homocystinuria Urine/serum copper for Wilson disease Karyotyping for a genetic defect GA work up
  • 17. MANAGEMENT Surgical or conservative mx ? If surgery,then what? Primary IOL implantation ? If not,how to manage aphakia?
  • 18. NON-SURGICAL Cataracts not in visual axis In visual axis but <3mm diameter Rx-Mydriatrics with part time occlusion of the better eye But prolonged cycloplegia causes amblyopia-early sx reqd
  • 19. SURGICAL-INDICATIONS Visually significant cataract-U/L or B/L U/L dense cataracts Central and >3mm Cataract with Strabismus Cataract with nystagmus or unsteady fixation One eye operated in a binocular cataract Poor retinoscopic reflex
  • 20. Small eyes/low scleral rigidity Positive pressure/elastic AC/difficult rhexis Biometry IOL power calculation Increased inflammatory response/constant change in refractive error Glaucoma/amblyopia/gla sses Post-op mx of aphakia/amblyopia CHALLENGES
  • 21. TIMING OF SURGERY Dense visually significant B/L cataract- 6-8 weeks of age (Each eye one week apart- to prevent amblyopia) U/L visually significant cataract -4-6 weeks B/L cataract detected later-surgery as soon as possible.First on the worse eye.
  • 22. Techniques of biometry ◦ Hand-held keratometer- lack of fixation and centration ◦ Inaccurate keratometric values-error of 0.8-1.3 D in children ◦ Obtaining multiple readings of the same and recording the average K reading ◦ K readings without speculum are preferred (causes globe deformation and gives unreliable readings)
  • 23. Techniques of biometry ◦ Inaccurate AL in paediatric eyes - 4-14 D of error for each mm difference ◦ For contact A-Scan,the value with maximum AC depth chosen to offset the inadvertent indentation of the cornea. ◦ Immersion A-Scan is considered gold standard
  • 24. IOL formulae AL <20mm- SRK/T and the Holladay 2 formulae OLDER CHILDREN(>2yrs) AL<22 MM –Hoffer Q formula AL>22 MM- Barrett and SRK/T formulas are better
  • 25. IOL POWER CALCULATION Aim for moderately hypermetropic postoperative refractive outcome to compensate for myopic shift which is expected in children due to axial elongation of the globe. IOL can be implanted in eyes with an AL >17mm and corneal diameter >10mm
  • 26. IOL POWER CALCULATION ◦ Dahan’s criteria: ◦ <2 yrs-undercorrect by 20% ◦ 2-8 yrs-undercorrect by 10% ◦ DAHAN’S GUIDELINES ◦ Hiles and Atkinson criteria: ◦ <2 yrs-20-50% undercorrect ◦ >2 yrs-emmetropic AXIAL LENGTH (MM) IOL POWER(D) 17 28 18 27 19 26 20 24 21 22
  • 27. IOL SIZE In children <2 yrs,smaller size (10-10.5mm)IOL must be used Adult size IOL (12-13.5mm) well tolerated in children >2 yrs d/t elastic nature of the capsule Optic size-5.5-6.5mm ensures adequate pupillary coverage in case of decentration
  • 28. IOL MATERIAL Acrylic Hydrophobic foldable IOL’s – Increased uveal biocompatibility,reduced post-op inflammation and PCO rates Single piece PMMA,preferably heparin coated- reduce deposits on IOL surface Children with juvenile rheumatoid arthritis,microcornea,microphthalmos,severe persistent foetal vasculature are left aphakic.
  • 29. IOL implantation ?? • IOL IMPLANTATION BEFORE 1 YR OF AGE CONTROVERSIAL • Difference in size of globe compared to adult eye & rapid growth(AL,corneal curvature,lens diameter&sulcus size). Unpredictable refractive status • Technical difficulty of implanting IOL in very small eyes • Greater inflammatory response • Secondary glaucoma • VAO • Most surgeons prefer implant after 18-24 months of age • Most of the growth of eye has occurred by this time • IOL power calculation is more predictable
  • 30.
  • 31. SURGICAL PRINCIPLES General Anaesthesia and EUA Lid speculum applied Superior rectus suture Wound construction Anterior capsulorrhexis Irrigation and aspiration Primary posterior capsulorrhexis Anterior vitrectomy IOL implantation Closure of wound with a suture
  • 32. General Anaesthesia and EUA Systemic co-morbidities Seizure disorders/developmental disorders Corneal diameter/biometry/IOP/IOL power cal/gonioscopy/pachymetry R/o NLD obstruction
  • 33. WOUND CONSTRUCTION ◦ LENSECTOMY ◦ -Limbal route/pars plana route ◦ -limbal:preservation of bag/360 capsular rim for secondary IOL ◦ -pars plana-2 side ports with MVR blade ◦ LENS ASPIRATION WITH PRIMARY IOL ◦ -clear corneal/scleral tunnel ◦ -2.8mm clear corneal main incision- preferred-foldable IOLs ◦ -5.5mm scleral tunnel-rigid PMMA IOLs
  • 34. Pre- requisites for ACC Adequate pupillary dilatation Improve visualization-use high magnification and dim OT lights Avoid positive vitreous pressure- pre-op iv mannitol may be reqd Viscolelastic-highly cohesive,use liberally
  • 35. Challenges –ACC ◦ A.)VERY ELASTIC CAPSULE- ◦ Deforms without tearing ◦ When it finally tears,the force of the rebound propagates the tear rapidly and uncontrollably to the periphery ◦ B.)LOW SCLERAL RIGIDITY ◦ Positive vitreous pressure shallowing of ac anterior surface of the lens becomes convex rhexis runs to periphery
  • 36. C.)DIFFICULT TO USE CYSTITOME Difficult to advance the everted capsular flap over soft cortex Less control over rhexis tends to extend D.)RHEXIS FORCEPS Better control over rhexis Utrata chances of AC shallowing as it is passed through main incision Special end-gripping type of rhexis forceps Introduced through side-port AC well-maintained
  • 37. Technique-ACC ◦ INITIAL CENTRAL PERFORATION-forceps -bent 26 G needle ◦ REST OF RHEXIS ◦ Forceps only ◦ Centripetal force instead of usual tangential (ripping technique) ◦ Peformed slowly with repeated re-grasping of flap just adjacent to edge of tear to prevent peripheral extension ◦ Always keep AC well-formed with visco-elastic ◦ Aim for small rhexis size as it enlarges due to elasticity ◦ Ideal size-5-5.5 mm ◦ ACC-smaller than the IOL optic diameter(6mm)
  • 38. ◦ RHEXIS BY RIPPING ◦ Flap pulled perpendicular to rhexis edge(i.e.towards centre) ◦ Only this method can tear the elastic capsule of children
  • 39. Other options ◦ VITRECTORRHEXIS ◦ Cutting rate 150-300 ◦ Aspiration rate 150-200cc/min ◦ 2 incision push-pull technique ◦ -2 small incisions superior & inferior ◦ -grasp the centre of flap of superior incision & push towards centre- semicircular tear ◦ -grasp the centre of flap of inferior incision & pull towards centre-semicircular tear RADIOFREQUENCY DIATHERMY CAPSULOTOMY High frequency current of 500khz Platinum alloy tip probe heated to 160 F
  • 40. Anterior capsulorrhexis Poor visibility/total cataracts Shallow AC Tendency to run off High PP from vitreous Elastic anterior capsule Run-off
  • 41. Irrigation and Aspiration Nucleus is very soft - Hence NO PHACO ENERGY needed Bimanual/co-axial probe-faster,maintains AC and prevents hypotony,hence pupillary miosis. Remove entire lens matter/cortex Polish the posterior capsule before PPC. Membranous /calcified cataracts may require phacoemulsification
  • 42. Primary posterior capsulorhexis Indicated in children <6years Planned posterior capsulotomy performed -to prevent inevitable PCO formation -to remove PC plaque -to allow posterior capture of IOL optic -to prevent radial extension when small PC rupture occurs inadvertently -to provide more tear resistant edge for anterior vitrectomy and IOL implantation
  • 43. Pre- requisites for PPC Excellent visibility – good microscope,clear cornea,sufficient mydriasis No positive pressure
  • 44. Technique-PPC ◦ Viscoelastic injected in capsular bag after cortical clean up-flattens PC by countering vitreous pressure ◦ Central perforation with cystitome in front of retrolental space of berger
  • 45. ◦ Central perforation ◦ -26G cystitome descends at a slant ◦ -PC engaged and punctured ◦ -small flap created by pushing margin inferiorly ◦ Small amount of viscoelastic injected into capsular hole ◦ -separates PC from vitreous ◦ -should be done slowly to avoid extension of tear to periphery
  • 46. ◦ Rhexis commenced with either utrata or end- gripping forceps ◦ -proceed slowly with repeated re-grasping of the leading edge in manner similar to anterior rhexis ◦ Rhexis size- ◦ -1.5-2mm smaller than IOL optic to reconstitute barrier between vitreous and anterior chamber ◦ -too small or too big will prevent IOL optic capture
  • 47. Anterior vitrectomy Intact anterior vitreous face(AVF) acts as scaffold for lens epithelial cells to grow-chances of VAO higher Mandatory in infants and younger children Maybe deferred in children >7years Limbal/transconjuctival pars plana approach Rates of PCO decreases only after AV not PCCC alone in children<6 years
  • 48. CURRENT RECOMMENDATION— Primary PCCC with AV for children <6-7 yrs of age Primary PCCC without AV for >7 yrs of age PC left intact in children >9-10 yrs of age
  • 49. IOL Implantation o Standard care-over 1 yr of age;infants-controversial? o Single piece hydrophobic acrylic IOL in the bag;inflate bag well with healon GV ◦ 3 piece IOL in sulcus ◦ Optic capture ◦ Bag in the lens technique
  • 50. IOL FIXATION SITES ◦ Haptics in bag & optic capture by PCCC ◦ Haptics & optic in bag (if PCCC too large or small for IOL capture) ◦ Haptics in sulcus & optic capture by PCCC(if incomplete anterior rhexis but complete PCCC) ◦ Haptics in sulcus & optic capture by anterior rhexis(if completenanterior rhexis but incomplete PCCC) ◦ Haptic in sulcus & optic in front of anterior capsule (if incomplete anterior rhexis & PCCC)
  • 51. Wound closure ◦ Wash all viscoelastic! ◦ Look for any peeking of rhexis/pupil-cut vitreous before wound closure ◦ LMW heparin solution(5IU in 500ml) may be used for irrigation to reduce chances of inflammation ◦ ALWAYS suture all the wounds (low scleral rigidity-not self-sealing wound) ◦ 10-0 vicryl/10-0 monofilament nylon suture ◦ Side ports may be left unsutured in older children if well constructed and no leak at the end of the procedure
  • 52. Post-op management ◦ Surgery is only the first and the easiest step! ◦ Topical steroids hourly doses tapered gradually ◦ Topical antibiotics broad spectrum ◦ Topical cycloplegics ◦ Oral steroids in special cases
  • 53. Management of aphakia ◦ SPECTACLES ◦ -B/L aphakia ◦ -most children adapt well and develop good visual responses ◦ -poor quality of vision;increased incidence of strabismus ◦ Poor cosmesis ◦ CONTACT LENSES ◦ -U/L and B/L aphakia ◦ -RGP/Silicone/hydrogel ◦ -better optical correction;comparable results to primary IOL implantation ◦ -difficult to insert/costly ◦ -risk of infection/intolerence
  • 54. Management of pseudophakia ◦ Undercorrection-less chances for higher myopic shift and IOL exchange at later date ◦ Spectacles-given as soon as surgery is done! ◦ Single vision correction for young infants;bifocals for toddlers;progressive glasses may be considered for older children ◦ Secondary IOL implantation in the sulcus-for aphakic cases @ 4-5 yrs of age
  • 55. COMPLICATIONS ◦ Post-op inflammation(fibrin/exudates)-start oral steriods ◦ Glaucoma ◦ Posterior capsular opacification ◦ Secondary membranes ◦ Pupillary capture of IOL/IOL decentration
  • 56. Amblyopia ◦ U/L cases most difficult to manage ◦ Starts right after surgery-aggressive part time occlusion ◦ B/L cases-check for fixation preference/BCVA at follow up visit and decide for PTO